氨基酸酸蛋白在炎症性肠病中的作用
Paul Grama1,2,3, Tamás Ilyés4, Naomi A Ciurea1,2
11st Internal Medicine Department, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mureș, Târgu Mureș, ROU.
Cureus
|November 7, 2025
概括
与健康个体相比,性结肠炎 (UC) 患者的血清中乙氨基蛋白 (ECP) 含量较高,这表明乙氨基在IBD病变发生过程中涉及乙氨基. 然而,在本研究中,ECP与疾病活性或生活质量没有相关性.
科学领域:
- 胃肠道学和免疫学
- 炎症性肠病 (IBD) 研究研究
- 生物标志物发现发现
背景情况:
- 埃索诺菲尔及其介质,如埃索诺菲尔酸蛋白 (ECP),与炎症性肠病 (IBD) 病原发生有关.
- 已知IBD生物标志物 (例如,C-反应蛋白,便calprotectin) 并不能完全捕捉出埃索诺菲尔的作用.
- 血清ECP作为IBD生物标志物的临床实用性仍然不清楚.
研究的目的:
- 为了比较性结肠炎 (UC),克罗恩病 (CD) 和健康对照中的血清ECP水平.
- 调查血清ECP和IBD疾病活动指数 (CDAI,梅奥得分) 和生活质量 (IBDQ) 之间的关联.
- 探索血清ECP和血液学参数 (白细胞,中性粒细胞,乙氨基粒细胞) 之间的相关性.
主要方法:
- 观察性研究包括50名IBD患者 (20CD,30UC) 和32名健康对照.
- 血清ECP通过酶免疫测试测量;使用CDAI,梅奥得分和IBDQ评估疾病活性和生活质量.
- 统计分析包括克鲁斯卡尔-瓦利斯,曼-惠特尼U测试和斯皮尔曼相关性.
主要成果:
- 与健康对照人群相比,UC患者的血清ECP水平显著更高 (p=0.008).
- 在CD患者和对照人群之间没有观察到血清ECP的显著差异 (p=0.418).
- 血清ECP与白细胞和中性粒细胞总数呈正相关性,但与疾病活性评分或IBDQ无相关性.
结论:
- 与对照组相比,UC患者的血清ECP升高,支持eosinophils在UC中的作用.
- 血清ECP没有与疾病活动指数 (CDAI,Mayo) 或生活质量 (IBDQ) 显示出强烈的相关性.
- 这些发现是产生假设的,需要前性验证,并且不确定血清ECP在IBD中的临床实用性.
相关概念视频
01:30Inflammatory Bowel Disease II: Crohn's Disease
939
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
939
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
622
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
622
01:22Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.6K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.6K
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
880
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
880
01:29Inflammatory Bowel Disease IV: Pharmacological Management
459
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
459
01:17Chronic Bowel Disorders: Introduction
736
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
736